Physician profile
John Werner
NPI 1437710100
$23,672.32
in general payments reported to CMS, 2019-2025
9 companies · $373 in 2025
The $373 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.18 · 2020: $342 · 2021: $342 · 2022: $1,710 · 2023: $671 · 2024: $20K · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $925 · Education: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $924.85 |
| Education | $333.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2024 | |
| Medical Device Business Services, INC. | $1,358.42 | 2020-2023 | |
| Conetic Solutions, INC. | $1,292.61 | 2022-2023 | |
| Stryker Corporation | $494.01 | 2019-2025 | 1788, Mako, Allofiber |
| Titan Surgical Group, LLC | $259.96 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $116.73 | 2023 | |
| Vericel Corporation | $67.57 | 2024-2025 | Maci |
| Sioux Surgical INC | $65.92 | 2025 | |
| Ferring Pharmaceuticals INC. | $17.10 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Werner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.